- Home
- FLUX vs PMN Comparison
FLUX vs PMN Comparison
Compare FLUX & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- PMN
- Stock Information
- Founded
- FLUX N/A
- PMN 2004
- Country
- FLUX United States
- PMN Canada
- Employees
- FLUX N/A
- PMN N/A
- Industry
- FLUX Industrial Machinery/Components
- PMN Pharmaceuticals and Biotechnology
- Sector
- FLUX Miscellaneous
- PMN Health Care
- Exchange
- FLUX Nasdaq
- PMN Nasdaq
- Market Cap
- FLUX 20.2M
- PMN 18.8M
- IPO Year
- FLUX N/A
- PMN N/A
- Fundamental
- Price
- FLUX $1.83
- PMN $0.51
- Analyst Decision
- FLUX Strong Buy
- PMN Strong Buy
- Analyst Count
- FLUX 3
- PMN 2
- Target Price
- FLUX $6.33
- PMN $4.50
- AVG Volume (30 Days)
- FLUX 38.2K
- PMN 55.0K
- Earning Date
- FLUX 05-08-2025
- PMN 05-12-2025
- Dividend Yield
- FLUX N/A
- PMN N/A
- EPS Growth
- FLUX N/A
- PMN N/A
- EPS
- FLUX N/A
- PMN N/A
- Revenue
- FLUX $63,074,000.00
- PMN N/A
- Revenue This Year
- FLUX $11.85
- PMN N/A
- Revenue Next Year
- FLUX $13.10
- PMN N/A
- P/E Ratio
- FLUX N/A
- PMN N/A
- Revenue Growth
- FLUX N/A
- PMN N/A
- 52 Week Low
- FLUX $1.15
- PMN $0.51
- 52 Week High
- FLUX $4.98
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- FLUX 54.30
- PMN 37.42
- Support Level
- FLUX $1.77
- PMN $0.48
- Resistance Level
- FLUX $2.13
- PMN $0.59
- Average True Range (ATR)
- FLUX 0.17
- PMN 0.07
- MACD
- FLUX 0.02
- PMN -0.01
- Stochastic Oscillator
- FLUX 45.45
- PMN 14.00
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.